AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sitazit-M ER 500 Tablet

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitazit-M ER 500 Tablet

Extended-release Sitazit-M 500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like nephropathy and vision loss, and may lessen the risk of cardiovascular events. Sitazit-M ER 500mg may be used alone or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under physician guidance. Maintaining your prescribed diet and exercise plan is crucial for diabetes management. Lifestyle significantly impacts blood sugar control. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse event, especially when combined with insulin or sulfonylureas; learn to recognize and manage this complication. This medication isn't suitable for all patients. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before initiating treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Potential drug interactions exist; disclose all medications to ensure treatment safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Sitazit-M ER 500 Tablet

No text provided to rephrase.

Uses of Sitazit-M ER 500 Tablet

Managing type 2 diabetes

Major Benefits of Sitazit-M ER 500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitazit-M ER 500 Tablet with a meal.

Common Side effects of Sitazit-M ER 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitazit-M ER 500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Take Sitazit-M ER 500 Tablet with food.

How Sitazit-M ER 500 Tablet works:

Sitagliptin and metformin, combined as Sitazit-M ER 500 Tablet, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and increasing insulin sensitivity. This dual mechanism provides superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitazit-M ER 500 Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitazit-M ER 500 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitazit-M 500 mg tablets may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, with the possibility of adverse effects on the nursing child.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitazit-M ER 500 Tablets cautiously, potentially requiring dosage modification. Consult a physician. The medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Extended-release Sitazit-M 500 mg tablets pose a likely risk for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Sitazit-M ER 500 Tablet :

Should you forget to take a Sitazit-M ER 500 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sitazit-M ER 500 Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Sitazit-M ER 500 Tablet

Sitazit-M ER 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitazit-M ER 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, such as numbness, tingling in extremities, weakness, urinary difficulties, cognitive changes, and balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitazit-M ER 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitazit-M ER 500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazit-M ER 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (Sitazit-M ER 500 Tablet) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess lactic acid in the blood. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Sitazit-M ER 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitazit-M ER 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitazit-M ER 500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitazit-M ER 500 Tablet and alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin + Metformin (Sitazit-M ER 500 Tablet) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitazit-M ER 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate these risks, yearly supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitazit-M ER 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitazit-M ER 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitazit-M ER 500 Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazit-M ER 500 Tablet and alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin + Metformin (Sitazit-M ER 500 Tablet) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitazit-M ER 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitazit-M ER 500 Tablet
212